Trial Profile
A study of tocilizumab for the treatment of juvenile idiopathic arthritis in young adults.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions
- 02 Feb 2016 New trial record